Bill > HB2213

This bill prohibits health carriers, health benefit plans, or utilization review organizations from using step therapy protocols to restrict, delay, or deny coverage for a prescription drug or drug regimen for the treatment of cancer and associated conditions, if certain criteria are met. The key terms defined in the bill include "associated conditions" (symptoms or side effects associated with cancer or its treatment), "cancer" (as defined in the existing law), and "healthcare practitioner" (a licensed physician, surgeon, or other healthcare professional engaged in diagnosing and treating patients with cancer). The bill applies to health insurance or health plans entered into, issued, delivered, amended, or renewed on or after July 1, 2024.